Advertisement
Australia markets close in 1 hour 3 minutes

  • ALL ORDS

    7,898.30
    +37.30 (+0.47%)
     

  • ASX 200

    7,642.20
    +36.60 (+0.48%)
     

  • AUD/USD

    0.6446
    +0.0009 (+0.14%)
     

  • OIL

    82.80
    +0.11 (+0.13%)
     

  • GOLD

    2,389.40
    +1.00 (+0.04%)
     

  • Bitcoin AUD

    95,763.82
    -3,942.28 (-3.95%)
     

  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     

  • AUD/EUR

    0.6034
    +0.0008 (+0.14%)
     

  • AUD/NZD

    1.0889
    +0.0016 (+0.14%)
     

  • NZX 50

    11,808.56
    -66.79 (-0.56%)
     

  • NASDAQ

    17,493.62
    -220.04 (-1.24%)
     

  • FTSE

    7,847.99
    +27.63 (+0.35%)
     

  • Dow Jones

    37,753.31
    -45.66 (-0.12%)
     

  • DAX

    17,770.02
    +3.79 (+0.02%)
     

  • Hang Seng

    16,469.29
    +217.45 (+1.34%)
     

  • NIKKEI 225

    38,092.55
    +130.75 (+0.34%)
     

Company News for Dec 5, 2019

Zacks Equity Research

  • HealthEquity Inc. HQY shares surge 3.4% after the company reported third-quarter fiscal 2020 adjusted earnings per share of $0.47, beating the Zacks Consensus Estimate of $0.22.

  • salesforce.com inc. CRM tumbled 3.2% after the company reduced its fiscal 2020 sales guidance to down 1% to up 1% from up 1% to up 3% provided earlier.

  • Shares of Campbell Soup Co. CPB increased 1.9% after posting first-quarter fiscal 2020 adjusted earnings per share of $0.78, surpassing the Zacks Consensus Estimate of $0.69.

  • Royal Bank of Canada RY dropped 1.5% after reporting fourth-quarter fiscal 2019 adjusted earnings per share of $1.68, outpacing the Zacks Consensus Estimate of $1.74.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Royal Bank Of Canada (RY) : Free Stock Analysis Report
 
salesforce.com, inc. (CRM) : Free Stock Analysis Report
 
Campbell Soup Company (CPB) : Free Stock Analysis Report
 
HealthEquity, Inc. (HQY) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research